Clinical Trial Update: Switch to Atazanavir and Brachial Artery Reactivity (SABAR) Study [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating switching HIV patients to atazanavir and its effect on brachial artery reactivity in individuals with hyperlipidemia; the study is co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hyperlipidemia

Drugs mentioned

• REYATAZ (atazanavir)

Snippet

Sponsor: Northwestern University | Conditions: HIV Infection, Hyperlipidemia | Phase 3 | Status: COMPLETED | Results posted: 2012-08-02